Literature DB >> 9651162

Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.

J S Kong1, S Venkatraman, K Furness, S Nimkar, T A Shepherd, Q M Wang, J Aubé, R P Hanzlik.   

Abstract

Human rhinovirus, the chief cause of the common cold, contains a positive-sense strand of RNA which is translated into a large polyprotein in infected cells. Cleavage of the latter to produce the mature viral proteins required for replication is catalyzed in large part by a virally encoded cysteine proteinase (3Cpro) which is highly selective for -Q approximately GP- cleavage sites. We synthesized peptidyl derivatives of vinylogous glutamine or methionine sulfone esters (e.g., Boc-Val-Leu-Phe-vGln-OR: R = Me, 1; R = Et, 2) and evaluated them as inhibitors of HRV-14 3C protease (3Cpro). Compounds 1 and 2 and several related tetra- and pentapeptide analogues rapidly inactivated 3Cpro with submicromolar IC50 values. Electrospray mass spectrometry confirmed the expected 1:1 stoichiometry of 3Cpro inactivation by 1, 2, and several other analogues. Compound 2 also proved to be useful for active site titration of 3Cpro, which has not been possible heretofore because of the lack of a suitable reagent. In contrast to 1, 2, and congeners, peptidyl Michael acceptors lacking a P4 residue have greatly reduced or negligible activity against 3Cpro, consistent with previously established structure-activity relationships for 3Cpro substrates. Hydrolysis of the P1 vinylogous glutamine ester to a carboxylic acid also decreased inhibitory activity considerably, consistent with the decreased reactivity of acrylic acids vs acrylic esters as Michael acceptors. Incorporating a vinylogous methionine sulfone ester in place of the corresponding glutamine derivative in 1 also reduced activity substantially. Compounds 1 and 2 and several of their analogues inhibited HRV replication in cell culture by 50% at low micromolar concentrations while showing little or no evidence of cytotoxicity at 10-fold higher concentrations. Peptidyl Michael acceptors and their analogues may prove useful as therapeutic agents for pathologies involving cysteine proteinase enzymes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651162     DOI: 10.1021/jm980114+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.

Authors:  L S Zalman; M A Brothers; P S Dragovich; R Zhou; T J Prins; S T Worland; A K Patick
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.

Authors:  A K Patick; S L Binford; M A Brothers; R L Jackson; C E Ford; M D Diem; F Maldonado; P S Dragovich; R Zhou; T J Prins; S A Fuhrman; J W Meador; L S Zalman; D A Matthews; S T Worland
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.

Authors:  Amy K Patick; Mary A Brothers; Fausto Maldonado; Susan Binford; Oscar Maldonado; Shella Fuhrman; Annkatrin Petersen; George J Smith; Leora S Zalman; Leigh Ann Burns-Naas; Jonathan Q Tran
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 4.  Organic carbamates in drug design and medicinal chemistry.

Authors:  Arun K Ghosh; Margherita Brindisi
Journal:  J Med Chem       Date:  2015-01-07       Impact factor: 7.446

5.  An NMR-Guided Screening Method for Selective Fragment Docking and Synthesis of a Warhead Inhibitor.

Authors:  Ram B Khattri; Daniel L Morris; Caroline M Davis; Stephanie M Bilinovich; Andrew J Caras; Matthew J Panzner; Michael A Debord; Thomas C Leeper
Journal:  Molecules       Date:  2016-07-16       Impact factor: 4.411

6.  Synthesis and testing of azaglutamine derivatives as inhibitors of hepatitis A virus (HAV) 3C proteinase.

Authors:  Y Huang; B A Malcolm; J C Vederas
Journal:  Bioorg Med Chem       Date:  1999-04       Impact factor: 3.641

Review 7.  Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells.

Authors:  Di Sun; Shun Chen; Anchun Cheng; Mingshu Wang
Journal:  Viruses       Date:  2016-03-17       Impact factor: 5.048

8.  QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro).

Authors:  Alex G Taranto; Paulo Carvalho; Mitchell A Avery
Journal:  J Mol Graph Model       Date:  2008-05-09       Impact factor: 2.518

9.  Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors.

Authors:  Magne O Sydnes; Yoshio Hayashi; Vinay K Sharma; Takashi Hamada; Usman Bacha; Jennifer Barrila; Ernesto Freire; Yoshiaki Kiso
Journal:  Tetrahedron       Date:  2006-07-14       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.